Patents by Inventor Bryan BURT

Bryan BURT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor
    Patent number: 11951182
    Abstract: An object of the present invention is to provide a method of treating thoracic cancer using a checkpoint inhibitor in combination with Ad-REIC/Dkk-3. The present invention is a pharmaceutical composition for treating thoracic cancer comprising REIC/Dkk-3 in combination with acheck point inhibitor and a method for treating thoracic cancer by administering Ad-REIC/Dkk-3 and a check point inhibitor to a thoracic cancer patient.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: April 9, 2024
    Assignee: Momotaro-Gene Inc.
    Inventors: Hiromi Kumon, Bryan Burt
  • METHOD AND SYSTEM FOR DETECTION AND ANALYSIS OF THORACIC OUTLET SYNDROME (TOS)
    Publication number: 20220160259
    Abstract: Motion data collected by a sensing device attached to a patient's arm may be used to determine whether the arm is subject to thoracic outlet syndrome (TOS) Motion data regarding motion of an arm of a patient may be received from a sensing device. One or more extremity performance parameters for the arm may be determined based, at least in part, on the motion data. A determination may be made based, at least in part, on the one or more extremity performance parameters whether the arm is subject to TOS.
    Type: Application
    Filed: April 2, 2020
    Publication date: May 26, 2022
    Applicant: Baylor College of Medicine
    Inventors: Bryan Burt, Bijan Najafi, Mohsen Zahiri, Changhong Wang
  • A COMBINATION THERAPY FOR TREATMENT OF THORACIC CANCER USING Ad-REIC/Dkk-3 AND A CHECKPOINT INHIBITOR
    Publication number: 20210402010
    Abstract: An object of the present invention is to provide a method of treating thoracic cancer using a checkpoint inhibitor in combination with Ad-REIC/Dkk-3. The present invention is a pharmaceutical composition for treating thoracic cancer comprising REIC/Dkk-3 in combination with a check point inhibitor and a method for treating thoracic cancer by administering Ad-REIC/Dkk-3 and a check point inhibitor to a thoracic cancer patient.
    Type: Application
    Filed: November 1, 2019
    Publication date: December 30, 2021
    Applicant: Momotaro-Gene Inc.
    Inventors: Hiromi KUMON, Bryan BURT